HomeInsightsDividend

Piramal Pharma Ltd dividend

Piramal Pharma Ltd dividend

download
stocks purchased

₹ 8.2 Cr

Volume transacted

stocks purchased

527.4 K

stocks traded

Last Updated time: 24 Jul 9.00 AM

Image

Piramal Pharma Ltd

NSE: PPLPHARMA

DPS

0.11

Last updated : FY 2024

Key Highlights

    The Dividend per Share of Piramal Pharma Ltd is ₹ 0.11 as of 2024 .a1#The Dividend Payout of Piramal Pharma Ltd changed from 18.07 % on March 2021 to 3.72 % on March 2024 . This represents a CAGR of -40.95% over 3 years. a1#The Latest Trading Price of Piramal Pharma Ltd is ₹ 156.25 as of 23 Jul 15:30 .a1#The Market Cap of Piramal Pharma Ltd changed from ₹ 8165 crore on March 2021 to ₹ 17052 crore on March 2024 . This represents a CAGR of 44.51% over 2 years. a1#The Revenue of Piramal Pharma Ltd changed from ₹ 1573 crore to ₹ 2590 crore over 8 quarters. This represents a CAGR of 28.31% a1#The EBITDA of Piramal Pharma Ltd changed from ₹ 108.82 crore to ₹ 537.83 crore over 8 quarters. This represents a CAGR of 122.31% a1#The Net Pr of Piramal Pharma Ltd changed from ₹ -109 crore to ₹ 101.27 crore over 8 quarters. This represents a CAGR of NaN% a1#

Open Demat Account

Lead form image

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

Share Price Vs Dividend Yield

swot
swot

Company Fundamentals For Piramal Pharma Ltd

Market Cap

20,714 Cr

EPS

0.1

P/E Ratio (TTM) *

0.0

P/B Ratio (TTM) *

2.6

DTE *

0.6

ROE *

0.2

ROCE *

5.4

Dividend Yield *

0.09

DPS *

0.11

Dividend Payout *

3.72

Ann.Dividend % *

1.1

* All values are consolidated

Last Updated time: 24 Jul 9.00 AM

* All values are consolidated

Last Updated time: 24 Jul 9.00 AM

×

Historical Dividend Payout of Piramal Pharma Ltd

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Historical Dividend Payout of Piramal Pharma Ltd

Period
Mar '210
Mar '2218
Mar '230
Mar '244

* All values are a in %

Dividend per Share (DPS) Over Time

×

DIVIDENDYIELD

Dividend Yield is a financial ratio that shows the annual dividend income relative to the market price of a share. It is calculated by dividing the dividend per share by the current market price per share, expressed as a percentage.

Dividend Yield Comparison With Top Peers

1M

1Y

3Y

5Y

* All values are in %

Net Profit Vs Dividend Per Share

Image

Piramal Pharma Ltd

NSE: PPLPHARMA

PRICE

156.25

4.80 (3.17%)

stock direction

Last updated : 23 Jul 15:30

SWOT Analysis Of Piramal Pharma Ltd

Strength

3

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Piramal Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Overview of Dividend

Types of Dividend


Special Dividend

A dividend is paid on common stock when a company has accumulated substantial profits over years, often seen as excess cash that doesn't need immediate use.


Preferred Dividend

A quarterly dividend is paid to preferred stock owners, typically accumulating a fixed amount, and is earned on shares that function more like bonds.


Interim Dividend

Companies declare interim dividends before final full-year accounts are prepared, specifically in India, during the financial year from April to March of the following year.


Final Dividend

A final dividend is issued after the year's accounts have been compiled. Aside from this, the following list highlights the most prevalent sorts of dividends:


×

Historical Market Cap of Piramal Pharma Ltd

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Historical Market Cap of Piramal Pharma Ltd

Period
Mar '210
Mar '220
Mar '238166
Mar '2417053

* All values are a in crore

×

Historical Revenue of Piramal Pharma Ltd

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Historical Revenue of Piramal Pharma Ltd

Period
Jun '221574
Sep '221777
Dec '221814
Mar '232196
Jun '231802
Sep '231980
Dec '232034
Mar '242591

* All values are a in crore

×

Historical EBITDA of Piramal Pharma Ltd

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

Historical EBITDA of Piramal Pharma Ltd

Period
Jun '22109
Sep '22223
Dec '22185
Mar '23384
Jun '23185
Sep '23334
Dec '23312
Mar '24538

* All values are a in crore

×

Historical Net Profit of Piramal Pharma Ltd

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Historical Net Profit of Piramal Pharma Ltd

Period
Jun '22-109
Sep '22-37
Dec '22-90
Mar '2350
Jun '23-99
Sep '235
Dec '2310
Mar '24101

* All values are a in crore

About Piramal Pharma Ltd

About Piramal Pharma Ltd

    Piramal Pharma Limited was incorporated on March 4, 2020 as a Public Limited Company and registered with the RoC. The Company offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 17 global facilities and a global distribution network in over 100 countries. It includes an integrated CDMO business, CHG business and ICH business, selling over-the-counter products in India. In addition, it has a joint venture with Allergan, a leader in ophthalmology in the Indian formulations market. Piramal Pharma Solution provides integrated drug discovery, development, and manufacturing services for both drug substances, i.e. active pharmaceutical ingredients (APIs) and drug products, i.e. formulations across the life cycle of a molecule, from discovery and clinical development to commercial launch. In addition, the Company has a joint venture (Allergan India Private Limited) with Allergan (now AbbVie), one of the market leaders in ophthalmology in the Indian formulations market. PPL holds 49% of the paid-up equity share capital in the joint venture. Further, PPL has a minority investment of 33.33% in Yapan Bio that operates in the biologics/ bio-therapeutics and vaccine segments. The Company is among the leading players in India in the self-care space, with established brands like Saridon, Supradyn, Lacto Calamine, Little's, Tetmosol, i-Pill and Polycrol. Apart from this, the Company offers differentiated capabilities in niches areas such as highly potent APIs, antibody drug conjugates, potent sterile injectables, hormonal oral solid dosage forms and biologics and vaccines. It has a global footprint with manufacturing capabilities across 15 facilities spanning across India, US, the UK and Canada. It also has global distribution network in over 100 countries. The Company's global distribution network gives it access to offer services and products to customers including large global pharma companies, biotech companies, hospitals and institutions. In June 2020, the Company acquired pharmaceutical business from Piramal Enterprises Limited (PEL). In October 2020, the Company received growth equity investment from the Carlyle Group. In It acquired 100% stake in Convergence Chemicals Private Limited (CCPL). It announced expansion for antibody drug conjugates at its Grangemouth (UK) facility and expansion of drug substance capabilities at its Riverview facility (USA). In 2021, it acquired Hemmo Pharmaceuticals Private Limited (HPPL), into the development and manufacturing of peptide APIs. On 7th October 2021, the Composite Scheme of Arrangement, which was entered into between the Company, Piramal Pharma Limited (PPL), Convergence Chemicals Private Limited (CCPL), Hemmo Pharmaceuticals Private Limited (HPPL), PHL Fininvest Private Limited (PFPL) and their respective shareholders and creditors for demerger of Pharma Business from Piramal Enterprises Limited (PEL) to PPL, amalgamation of CCPL and HPPL (both being wholly owned subsidiaries of PPL) into PPL; and the amalgamation of PFPL (a wholly owned subsidiary of PEL) into PEL was effective from August 18, 2022. In consideration for the demerger, the equity shareholders of PEL as on the demerger record date received 4 equity shares of face and paid-up value of Rs 10 each of the Company for every 1 equity share of face and paid-up value of Rs 2 each held in PEL. i.e. 4:1. Accordingly, the Company was listed on the Stock Exchanges, BSE Limited (BSE) and National Stock Exchange of India Limited 'NSE) on October 19, 2022. In 2022, the Company acquired minority stake in Yapan Bio Private Limited, an India-Based CDMO providing expertise in biologics and vaccines. It launched 26 New products and 37 new SKUs during FY 2023.

Piramal Pharma Ltd News Hub

News

Piramal Pharma to table results

Piramal Pharma will hold a meeting of the Board of Directors of the Company on 26 July 202...

Read more

16 Jul 202410:59

News

Piramal Pharma’s Ahmedabad facility gets zero USFDA observations

The United States Food and Drug Administration (USFDA) inspection was completed successful...

Read more

15 Jul 202408:53

News

Piramal Pharma to hold AGM

Piramal Pharma announced that the Annual General Meeting (AGM) of the company will be held...

Read more

12 Jun 202413:44

News

Piramal Pharma fixes record date for final dividend

Piramal Pharma has fixed 12 July 2024 as record date for the purpose of determining the me...

Read more

11 Jun 202416:51

News

Piramal Pharma's Lexington facility completes USFDA inspection

Piramal Pharma announced that US FDA has issued an Establishment Inspection Report (EIR) f...

Read more

23 May 202410:49

News

Board of Piramal Pharma recommends final dividend

Piramal Pharma announced that the Board of Directors of the Company at its meeting held on...

Read more

11 May 202409:40

FAQs for dividends of Piramal Pharma Ltd

What is the current market price of Piramal Pharma Ltd Ltd as of July 24, 2024?

The current market price of Piramal Pharma Ltd Ltd stands at 156.3 per share.

What dividend did Piramal Pharma Ltd declare in the last fiscal year?

In the last fiscal year, Piramal Pharma Ltd declared a dividend totaling ₹0.0.

What is the most recent dividend declared by Piramal Pharma Ltd?

Piramal Pharma Ltd recently declared a dividend of 0.0 in the latest quarter

How many times has Piramal Pharma Ltd declared dividends in the current fiscal year

Piramal Pharma Ltd has declared dividends 4 times totaling ₹0 in the current fiscal year (FY2023-2024).

How many times did Piramal Pharma Ltd declare dividends in the previous fiscal year?

In the previous fiscal year (FY2022-2023), Piramal Pharma Ltd declared dividends 4 times totaling ₹0.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199